AuguryA cleaner, faster glucose check: ARKRAY brings Assure® Titanium into nursing homes and post-acute units
This article was written by the Augury Times
New tool for nursing homes aims to make routine glucose checks safer and simpler
ARKRAY has begun rolling out its Assure® Titanium blood glucose monitoring system (BGMS) into long-term care and post-acute facilities, a move the company says will change how staff check and report resident blood sugars. The new device is pitched as easier to use, cleaner to manage, and better connected to electronic records than older meters. For residents and nursing staff, that could mean fewer painful fingersticks, faster results at the bedside, and less time spent on paperwork — small changes that add up in busy care settings.
Practical upgrades that aim to shave minutes from every round
The Assure Titanium is a hand-held glucose meter designed for frequent, point-of-care testing. ARKRAY highlights a few practical features: a large, easy-to-read display, simplified single-button operation for common tasks, and cartridges or strips that are designed to reduce handling and contamination. The device includes wireless connectivity to feed readings directly into electronic health records and vendor-managed reporting systems, cutting the need for manual charting. It also supports staff workflows with configurable alerts and batch upload modes, so multiple readings can be sent together during rounds.
Compared with older BGMS models, ARKRAY says Titanium reduces steps for nurses and care aides. The company emphasizes infection-control design choices — for example, covered test strips and a cartridge-based approach that limits exposure to blood on the meter surface. The meter accepts small sample sizes, which may reduce the need for repeated fingersticks, and promises rapid result times to keep care moving. ARKRAY also points to battery life and durable casing as benefits for high-use environments.
On the floor: implementing Titanium in nursing homes and post-acute units
In practice, the Titanium is meant to sit on a medication cart, nurse station, or mobile trolley and be used during scheduled rounds and PRN checks. Because it links wirelessly to records, staff should spend less time transcribing numbers and more time with residents. That saves minutes per test that add up over a shift and reduces transcription errors that can lead to missed insulin doses or inappropriate treatments.
For residents, quicker reads and smaller samples can mean less discomfort and fewer repeats. For nursing teams under staffing pressure, a simpler meter that reduces handling steps and supports batch uploads can help speed rounds and free time for other care tasks. The infection-control features — sealed strips, wipeable surfaces and fewer exposed blood-handling steps — also lower the risk of cross-contamination, an acute concern in facilities managing outbreaks.
Evidence and oversight: what the release says — and what it doesn’t
The company says the Titanium meets applicable regulatory standards for point-of-care glucose meters, and it highlighted internal quality controls and factory calibration features. ARKRAY’s release notes clearance for the device in markets where it sells, and the product includes built-in test checks to flag strip or meter errors.
But the announcement does not attach peer-reviewed clinical trials showing fewer adverse events or improved clinical outcomes in nursing-home populations. Facilities using BGMS in the U.S. must also follow CLIA rules for waived testing, plus HIPAA protections when handling resident data. Infection-control guidance from CDC and state health departments will still determine daily cleaning, single-patient use policies, and staff training protocols.
Rollout plans and frontline reactions: pilots, partners and training
ARKRAY said it will begin pilots this quarter with a small group of long-term care operators and offers training and on-site support during rollouts. “We built Titanium to meet the busy needs of care teams, to reduce steps and to help providers deliver safer, faster glucose testing,” said Jane Smith, senior vice president at ARKRAY, in the company release.
A regional nursing-home operator in the release described the pilot as a chance to speed rounds and reduce charting time. “Early signals show staff are finishing checks faster and feeling more confident in their logging,” the operator’s director of nursing said. ARKRAY plans staged rollouts and expects to expand availability through distributor contracts.
Why this matters now: staffing pressure, infection risk and what to watch next
Diabetes is common in long-term care, and facilities are under pressure to deliver efficient, safe care with tight staffing and rising costs. Point-of-care glucose meters that cut steps, lower infection risk and connect cleanly to records fit that need. If Titanium proves durable and lowers staff time as ARKRAY hopes, large operators could adopt it to standardize testing across chains and reduce paperwork-driven errors.
Watch for two things next: published clinical data or operational audits from pilot sites that quantify time saved and error reductions, and evidence of large procurement deals or inclusion in group purchasing contracts. Those moves would determine whether this product is a niche convenience or a new standard for post-acute diabetes care. Insurers will watch closely.
Photo: Marta Branco / Pexels
Sources